Targeting astrocytes in major depression

Expert Review of Neurotherapeutics

Volumn 15, Issue 11, 2015, Pages 1299-1306

  Peng, Liang ^a   Verkhratsky, Alexei ^b,c,d,e   Gu, Li ^a   Li, Baoman ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

Author keywords

astrocytes; major depression; mechanism of drug action; neuropsychiatric diseases; serotonin specific reuptake inhibitors

Indexed keywords

4 AMINOBUTYRIC ACID; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CITALOPRAM; FIBROBLAST GROWTH FACTOR 2; FLUOXETINE; FLUVOXAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; KAINIC ACID RECEPTOR; KETAMINE; MITOGEN ACTIVATED PROTEIN KINASE 3; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; POTASSIUM; RILUZOLE; SEROTONIN; SEROTONIN 2B RECEPTOR; SERTRALINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; VASCULOTROPIN; VOLINANSERIN;

ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; BRAIN TISSUE; CELL DENSITY; CELL STRUCTURE; DRUG EFFECT; GLUTAMATERGIC SYNAPSE; HUMAN; LONG TERM CARE; MACROGLIA; MAJOR DEPRESSION; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; THERAPY EFFECT; DRUG EFFECTS; PATHOLOGY; SYNAPSE; SYNAPTIC TRANSMISSION;

ANTIDEPRESSIVE AGENTS; ASTROCYTES; DEPRESSIVE DISORDER, MAJOR; HUMANS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84947866698     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2015.1095094     Document Type: Review

References (80)

1. Kettenmann H, Kirchhoff F, Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron 2013;77:10-18
2. Verkhratsky A, Butt AM. Glial physiology and pathophysiology. Wiley-Blackwell; Chichester: 2013
3. Hertz L. Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacol 2008;55:289-309
4. Rose CF, Verkhratsky A, Parpura V. Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans 2013;41:1518-24
5. Zhou Y, Danbolt NC. Glutamate as a neurotransmitter in the healthy brain. J Neural Transm 2014;121:799-817
6. Hertz L. Astrocytic energy metabolism and glutamate formation-relevance for 13C-NMR spectroscopy and importance of cytosolic/mitochondrial trafficking. Magn Reson Imaging 2011;29:1319-29
7. Parpura V, Grubisic V, Verkhratsky A. Ca2+ sources for the exocytotic release of glutamate from astrocytes. Biochim Biophys Acta 2011;1813:984-91
8. Hertz L, Rothman DL, Li B, et al. Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift. Front Behav Neurosci 2015;9:25
9. Verkhratsky A, Parpura V. Verkhratsky, Recent advances in (patho)physiology of astroglia. Acta Pharmacol Sin 2010;31: 1044-54
10. Verkhratsky A, Rodriguez JJ, Parpura V. Calcium signalling in astroglia. Mol Cell Endocrinol 2012;353:45-56
11. Kirischuk S, Parpura V, Verkhratsky A. Sodium dynamics: another key to astroglial excitability? Trends Neurosci 2012;35: 497-506
12. Muller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007;12: 988-1000
13. Hertz L. Astrocytic energy metabolism and glutamate formation-relevance for 13C-NMR spectroscopy and importance of cytosolic/mitochondrial trafficking. Magn Reson Imaging 2011;29:1319-29
14. Rajkowska G, Stockmeier CA. Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets 2013;14:1225-36
15. Benton CS, Miller BH, Skwerer S, et al. Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology (Berl) 2012;221:297-315
16. Sun JD, Liu Y, Yuan YH, et al. Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 2012;37: 1305-20
17. Bechtholt-Gompf AJ, Walther HV, Adams MA, et al. Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology 2010;35: 2049-59
18. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012;62: 63-77
19. Verkhratsky A, Parpura V. Neurological and psychiatric disorders as a neuroglial failure. Period Biol 2014;116:115-24
20. Paslakis G, Gass P, Deuschle M. [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data]. Fortschr Neurol Psychiatr 2011;79:204-12
21. De Vasconcellos-Bittencourt AP, Vendite DA, Nassif M, et al. Chronic stress and lithium treatments alter hippocampal glutamate uptake and release in the rat and potentiate necrotic cellular death after oxygen and glucose deprivation. Neurochem Res 2011;36:793-800
22. Almeida RF, Thomazi AP, Godinho GF, et al. Effects of depressive-like behavior of rats on brain glutamate uptake. Neurochem Res 2010;35:1164-71
23. Lapidus KA, Soleimani L, Murrough JW. Novel glutamatergic drugs for the treatment of mood disorders. Neuropsychiatr Dis Treat 2013;9:1101-12
24. Hertz L, Li B, Song D, et al. Astrocytes as a 5-HT2B-Mediated SSRI, SERT-independent target, slowly altering depression-associated genes and function. Curr Signal Transduct Ther 2012;7:43-55
25. Diaz SL, Doly S, Narboux-Nême N, et al. 5-HT2B receptors are required for serotonin-selective antidepressant actions. Mol Psychiatry 2012;17:54-63
26. Schipke CG, Heuser I, Peters O. Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex. J Psychiatr Res 2011;45:242-8
27. Peng L, Huang J. Astrocytic 5-HT2B receptor as in vitro and in vivo target of SSRIs. Recent Pat CNS Drug Discov 2012;7:243-53
28. Hertz L, Song D, Li B, et al. Importance of 'inflammatory molecules', but not necessarily of inflammation, in the pathophysiology of bipolar disorder and in the mechanisms of action of anti-bipolar drugs. Neurology Psychiatry Brain Res 2013;19:174-9
29. Li B, Zhang S, Zhang H, et al. Fluoxetine affects GluK2 editing, glutamate-evoked Ca2+ influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes. J Psychiatry Neurosci 2011;36:322-38
30. Li B, Dong L, Wang B, et al. Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia. J Neurochem Res 2012;37:2480-95
31. Mercier G, Lennon AM, Renouf B, et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci 2004;24:207-16
32. Prickaerts J, De Vry J, Boere J, et al. Differential BDNF responses of triple versus dual reuptake inhibition in neuronal and astrocytoma cells as well as in rat hippocampus and prefrontal cortex. J Mol Neurosci 2012;48:167-75
33. Allaman I, Fiumelli H, Magistretti PJ, et al. Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl) 2011;216:75-84
34. Quesseveur G, David DJ, Gaillard MC, et al. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Transl Psychiatry 2013;3:e253
35. Vollmayr B, Mahlstedt MM, Henn FA. Neurogenesis and depression: what animal models tell us about the link. Eur Arch Psychiatry Clin Neurosci 2007;257:300-3
36. Verkhratsky A, Parpura V. Store-operated calcium entry in neuroglia. Neurosci Bull 2014;30:125-33
37. Li B, Dong L, Fu H, et al. Effects of chronic treatment with fluoxetine on receptor-stimulated increase of [Ca2+]i in astrocytes mimic those of acute inhibition of TRPC1 channel activity. Cell Calcium 2011;50:42-53
38. Manev H, Uz T, Manev R. Glia as a putative target for antidepressant treatments. J Affect Disord 2003;75:59-64
39. Li B, Gu L, Hertz L, et al. Expression of nucleoside transporter in freshly isolated neurons and astrocytes from mouse brain. Neurochem Res 2013;38:2351-8
40. Nagai K, Konishi H. Effect of fluoxetine and pergolide on expression of nucleoside transporters and nucleic-related enzymes in mouse brain. Fundam Clin Pharmacol 2014;28:217-20
41. Hetzel G, Moeller O, Evers S, et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology (Berl) 2005;178:161-6
42. Luo KR, Hong CJ, Liou YJ, et al. Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1433-9
43. Tramontina AC, Tramontina F, Bobermin LD, et al. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1580-3
44. Nagelhus EA, Veruki ML, Torp R, et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes. J Neurosci 1998;18:2506-19
45. Czeh B, Di Benedetto B. Antidepressants act directly on astrocytes: evidences and functional consequences. Eur Neuropsychopharmacol 2013;23:171-85
46. Bernard R, Kerman IA, Thompson RC, et al. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 2011;16:634-46
47. Kong H, Sha LL, Fan Y, et al. Requirement of AQP4 for antidepressive efficiency of fluoxetine: implication in adult hippocampal neurogenesis. Neuropsychopharmacology 2009;34:1263-76
48. Czeh B, Simon M, Schmelting B, et al. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 2006;31: 1616-26
49. Jaako K, Zharkovsky T, Zharkovsky A. Effects of repeated citalopram treatment on kainic acid-induced neurogenesis in adult mouse hippocampus. Brain Res 2009;1288: 18-28
50. Al-Amin MM, Uddin MM, Rahman MM, et al. Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture. Inflammopharmacology 2013;21:421-5
51. Hisaoka K, Nishida A, Koda T, et al. Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem 2001;79:25-34
52. Kajitani N, Hisaoka-Nakashima K, Morioka N, et al. Antidepressant acts on astrocytes leading to an increase in the expression of neurotrophic/growth factors: differential regulation of FGF-2 by noradrenaline. PLoS One 2012;7:e51197
53. Kim Y, Kim SH, Kim YS. Imipramine activates glial cell line-derived neurotrophic factor via early growth response gene 1 in astrocytes. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1026-32
54. Hisaoka K, Tsuchioka M, Yano R, et al. Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production. J Biol Chem 2011;286: 21118-28
55. Kittel-Schneider S, Kenis G, Schek J, et al. Expression of monoamine transporters, nitric oxide synthase 3, and neurotrophin genes in antidepressant-stimulated astrocytes. Front Psychiatry 2012;3:33
56. Takano K, Yamasaki H, Kawabe K, et al. Imipramine induces brain-derived neurotrophic factor mRNA expression in cultured astrocytes. J Pharmacol Sci 2012;120:176-86
57. Macaulay N. Zeuthen T. Glial K. Clearance and cell swelling: key roles for cotransporters and pumps. Neurochem Res 2012;37:2299-309
58. Xu J, Song D, Xue Z, et al. Requirement of glycogenolysis for uptake of increased extracellular K+ in astrocytes: potential implications for K+ homeostasis and glycogen usage in brain. Neurochem Res 2013;38:472-85
59. Hertz L, Xu J, Song D, et al. Brain glycogenolysis, adrenoceptors, pyruvate carboxylase, Na+,K+-ATPase and Marie E. Gibbs' pioneering learning studies. Front Integr Neurosci 2013;7:20
60. D'Ambrosio R Gordon DS, Winn HR. Differential role of KIR channel and Na+/K +-pump in the regulation of extracellular K+ in rat hippocampus. J Neurophysiol 2002;87:87-102
61. Su S, Ohno Y, Lossin C, et al. Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline. J Pharmacol Exp Ther 2007;320:573-80
62. Ohno Y, Hibino H, Lossin C, et al. Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors. Brain Res 2007;1178:44-51
63. Furutani K, Ohno Y, Inanobe A, et al. Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel. Mol Pharmacol 2009;75:1287-95
64. Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 2000;11:483-6
65. Hwang J, Zheng LT, Ock J, et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008;55:826-34
66. Lee YH, Kim SH, Kim Y, et al. Inhibitory effect of the antidepressant imipramine on NF-kB-dependent CXCL1 expression in TNFa-exposed astrocytes. Int Immunopharmacol 2012;12:547-55
67. Obuchowicz E, Kowalski J, Labuzek K, et al. Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol 2006;9:27-35
68. Cho W, Brenner M, Peters N, et al. Drug screening to identify suppressors of GFAP expression. Hum Mol Genet 2010;19: 3169-78
69. Gabryel B, Bielecka A, Stolecka A, et al. Cytosolic phospholipase A2 inhibition is involved in the protective effect of nortriptyline in primary astrocyte cultures exposed to combined oxygen-glucose deprivation. Pharmacol Rep 2010;62:814-26
70. Harkin A, Nally R, Kelly JP, et al. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta 1-adrenergic receptors in an animal model of depression. J Neural Transm 2000;107: 1213-27
71. Hundal Ø. Major depressive disorder viewed as a dysfunction in astroglial bioenergetics. Med Hypotheses 2007;68: 370-7
72. Trzeciak HI, Pudeko A, Gabryel B, et al. Effect of antidepressants on ATP content, 3H-valine incorporation and cell morphometry of astrocytes cultured from rat brain. Dev Neurosci 1995;17:292-9
73. Cao X, Li LP, Wang Q, et al. Astrocyte-derived ATP modulates depressive-like behaviors. Nat Med 2013;19: 773-7
74. Melas PA, Rogdaki M, Lennartsson A, et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol 2012;15:669-79
75. Zimmermann N, Zschocke J, Perisic T, et al. Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. Biochem J 2012;448:93-102
76. Gourley SL, Espitia JW, Sanacora G, et al. Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice. Psychopharmacology (Berl) 2012;219: 805-14
77. Yoshizumi M, Eisenach JC, Hayashida K. Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes. Eur J Pharmacol 2012;677:87-92
78. Carbone M, Duty S, Rattray M. Riluzole elevates GLT-1 activity and levels in striatal astrocytes. Neurochem Int 2012;60:31-8
79. Mizuta I, Ohta M, Ohta K, et al. Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neurosci Lett 2001;310:117-20
80. Tsuchioka M, Hisaoka K, Yano R, et al. Riluzole-induced glial cell line-derived neurotrophic factor production is regulated through fibroblast growth factor receptor signaling in rat C6 glioma cells. Brain Res 2011;1384:1-8